Aster DM Healthcare Ltd. saw a 10% jump in its share price following the release of its Q2 FY25 results, which showed impressive financial performance. The company reported a 17% year-on-year (YoY) increase in revenue, climbing to ₹11,216.8 million from ₹9,332.1 million in the same quarter last year. Aster DM also achieved a notable improvement in its operating margin, which increased by 460 basis points (bps) YoY.
Key Highlights:
- Revenue: ₹11,216.8 million, up from ₹9,332.1 million in Q2 FY24.
- Net Income: ₹968.4 million, a strong recovery from a net loss of ₹308 million in Q2 FY24.
- Earnings Per Share (EPS): Basic EPS from continuing operations increased to ₹1.94 from ₹0.94 a year ago.
For the first half of FY25, the company’s total sales reached ₹20,883.1 million, up from ₹17,706.4 million a year earlier, while net income surged to ₹52,420.2 million from a net loss of ₹258.9 million during the same period last year.
As of 9:20 AM, Aster DM’s shares were trading 10.01% higher at ₹442.25 on the NSE.
